Measuring cerebral atrophy and white matter hyperintensity burden to predict the rate of cognitive decline in Alzheimer disease - Wikidata - wikimedia - TriplyDB

Measuring cerebral atrophy and white matter hyperintensity burden to predict the rate of cognitive decline in Alzheimer disease

Measuring cerebral atrophy and white matter hyperintensity burden to predict the rate of cognitive decline in Alzheimer disease

http://www.wikidata.org/entity/Q37067814

about

Long-term blood pressure fluctuation and cerebrovascular disease in an elderly cohort How does it STAC up? Revisiting the scaffolding theory of aging and cognition Advances in longitudinal studies of amnestic mild cognitive impairment and Alzheimer's disease based on multi-modal MRI techniques.Metabolic, inflammatory, and microvascular determinants of white matter disease and cognitive decline.Gene expression patterns associated with neurological disease in human HIV infection Alcohol intake and brain structure in a multiethnic elderly cohort.Structural neuroimaging in Altheimer's disease: do white matter hyperintensities matter?Predicting aggressive decline in mild cognitive impairment: the importance of white matter hyperintensities White matter hyperintensities and cognition: testing the reserve hypothesis.White matter hyperintensities and cerebral amyloidosis: necessary and sufficient for clinical expression of Alzheimer disease?Soluble amyloid beta levels are elevated in the white matter of Alzheimer's patients, independent of cortical plaque severity.Brain imaging in the study of Alzheimer's disease Different associations of white matter lesions with depression and cognition.APOE ε4 and risk for Alzheimer's disease: do regionally distributed white matter hyperintensities play a role?Brain structure and cerebrovascular risk in cognitively impaired patients: Shanghai Community Brain Health Initiative-pilot phase.Reconsidering harbingers of dementia: progression of parietal lobe white matter hyperintensities predicts Alzheimer's disease incidence.Contemplating Alzheimer's disease and the contribution of white matter hyperintensities.Measuring cognitive reserve based on the decomposition of episodic memory variance Quantitative approaches for assessment of white matter hyperintensities in elderly populations Vascular disease and risk factors are associated with cognitive decline in the alzheimer disease spectrum.Cerebral autoregulation, beta amyloid, and white matter hyperintensities are interrelated Apolipoprotein E-dependent load of white matter hyperintensities in Alzheimer's disease: a voxel-based lesion mapping study Altered temporal lobe white matter lipid ion profiles in an experimental model of sporadic Alzheimer's disease.The effect of white matter hyperintensities on neurodegeneration in mild cognitive impairment.Combining structural brain changes improves the prediction of Alzheimer's disease and mild cognitive impairment.White matter predictors of cognitive functioning in older adults.Effects of general medical health on Alzheimer's progression: the Cache County Dementia Progression Study Regional white matter hyperintensity volume, not hippocampal atrophy, predicts incident Alzheimer disease in the community.Assessment of cognition in early dementia.Relationship between White Matter Lesions and Progression of Cognitive Decline in Alzheimer's Disease White matter hyperintensities and amyloid are independently associated with entorhinal cortex volume among individuals with mild cognitive impairment Age-associated leukoaraiosis and cortical cholinergic deafferentation.Diet and Neuroimaging Markers of Cerebrovascular Disease Cognitive aging in persons with minimal amyloid-β and white matter hyperintensities.Reduction in cerebral blood flow in areas appearing as white matter hyperintensities on magnetic resonance imaging.Brain volumetric, regional cortical thickness and radiographic findings in adults with cyanotic congenital heart disease.Neuroradiologic correlates of clinical disability and progression in the X-linked leukodystrophy Pelizaeus-Merzbacher disease Postmortem MRI: a novel window into the neurobiology of late life cognitive decline Biochemical and Radiological Markers of Alzheimer's Disease Progression.MRI Markers Predict Cognitive Decline Assessed by Telephone Interview: The Northern Manhattan Study.

P2860

Q24595629-58262D51-4168-4C05-A698-C46BB266B2B0 Q26827532-70728299-7768-4CFC-B535-15D71D69CD9A Q30765803-548585B1-C9B8-46DF-AEC0-2666EB51093E Q31154291-B79C3031-CA92-43D2-823B-8EF377785302 Q33605737-BE278AF4-8C20-4862-9B19-EA298ABE859C Q33721811-16003469-D520-4E0D-BC02-FD258B2725BC Q33828173-05A4C93F-A370-4449-B197-B5E0BA1DA7A8 Q33938347-CF04B8FE-49E6-4A46-B7E3-9DCE19B9308B Q33938999-07D4F8A7-6C51-4173-9BE3-09785AAEBCB8 Q34013887-7AF3CEE5-77C6-45DF-8A8A-6060929195FD Q34100175-A2939B34-C558-460E-9070-4129D91A1BF2 Q34102331-9BA1BAAC-704F-4264-BFAC-585CAC4B8666 Q34392959-05A689E9-11D6-41B8-85F2-50E01D9DBFA2 Q34613047-0503B602-1AD4-4D63-B090-8F8C63D6998B Q34636326-716A8D69-2882-4C85-9C7E-DE1BB19A056F Q34714991-DF0D47E8-57B7-46F1-80BB-BCA363550D4F Q35031724-ECDF93B2-795F-46C7-BEEA-76D4A76CD817 Q35116519-472FA017-7B01-4ABE-8E3B-29A83FB2C188 Q35189928-07A860B8-957B-4B09-A498-02F9110AFEFD Q35195389-9B272C86-AFE8-4686-BCC7-CFF0805D8614 Q35604010-2BEF635B-F5B4-4AC8-B34C-F1D90218AC18 Q35610026-E5ED11FE-360C-4993-88E4-376F7AB1B3A4 Q36355644-DD850AE5-7349-43E6-ADC4-45DC4208013D Q36366566-F9D0A64C-1E5A-4AE1-A970-770AE1AA7DAD Q36374662-2EFB88D2-181D-4D6C-AEDB-8AF0BAD2CFA5 Q36590418-4C0503C8-503A-482A-8992-3B0822878DB5 Q36613964-93D9940F-47CD-405D-8DC9-27932A2157EB Q36684239-47E3BF9D-D217-4608-BE9F-8FF37DAA4656 Q36733293-54433725-1464-4B56-8BD3-20D25F11CF49 Q36802976-BA77FB3E-9C43-44CF-A6C5-659826CD8D6D Q36874831-8621200D-307A-4F87-81CB-9584E416F0C1 Q37180493-F336C934-0F9C-4301-B431-A72FC182F4EF Q37188900-76690E58-DD67-4DE2-8498-613858E368A7 Q37252248-D68D67F6-6684-4FB7-AAAC-7FEBD036AE8E Q37390713-05EAE783-1ED4-478F-B043-58B342189E93 Q37554847-605DB198-4417-4B11-AD6A-5783F354B016 Q37672290-8B3A25A9-985A-4462-895F-4CC1E66D37D1 Q38389594-93D02576-27D7-4922-9E61-6A5E6920BD42 Q38693438-61EE214A-EA4A-480B-A1EA-C40CF332F491 Q39551185-4D13AD7C-AF32-4D47-98CF-2246F19DE06A

P2860

Measuring cerebral atrophy and white matter hyperintensity burden to predict the rate of cognitive decline in Alzheimer disease

http://www.wikidata.org/entity/Q37067814

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on September 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Measuring cerebral atrophy and ...... e decline in Alzheimer disease

@en

Measuring cerebral atrophy and ...... decline in Alzheimer disease.

@nl

type

label

Measuring cerebral atrophy and ...... e decline in Alzheimer disease

@en

Measuring cerebral atrophy and ...... decline in Alzheimer disease.

@nl

prefLabel

Measuring cerebral atrophy and ...... e decline in Alzheimer disease

@en

Measuring cerebral atrophy and ...... decline in Alzheimer disease.

@nl

P1433

Q37067814-94A8E90A-F5AE-4312-B553-E092A3569F12

P1476

Q37067814-BF528BE3-F0FE-4C90-9C09-F661A54B0BF3

P2093

Q37067814-03C49C27-723E-45F7-9827-BE4658EEE172

Q37067814-2F5329AF-E460-459D-B68B-259699E0FE0F

Q37067814-5E9BCF0E-AF2E-4FB2-87DC-0484D3AB2371

Q37067814-7250951D-8A80-4184-8DAB-C54F6205CA63

Q37067814-AC0C5479-840C-4832-9294-63702A0B0F20

Q37067814-D9AF5CBE-6133-45B8-A821-2BE5113F7CB7

P2860

Q37067814-01139AA7-A938-4C13-8CE7-C73BF4C7945E

Q37067814-086B4072-07C5-4E5A-897A-11ED1DDBFD72

Q37067814-0A3AFEE7-880B-4356-9FCD-56E8B2CA83EF

Q37067814-0E8A4FFD-0024-44C7-8EFE-8A9D53D6AAF1

Q37067814-12CECBDB-2C75-44E1-9F51-ED2679052442

Q37067814-165D5769-8A2D-4540-8ABA-CD11F9F3017B

Q37067814-18627C2A-F91F-45FE-862B-6D1174ECAAB2

Q37067814-2C5AB71A-CA10-48DD-92DA-4827F59EC82C

Q37067814-2CAB7467-95AA-4B45-A815-429C8734DEA8

Q37067814-2FC5E8AF-F587-4190-A64C-9C2B9ACF1093

P304

Q37067814-A38B1727-0827-40D1-804E-38D07ACAB5AE

P31

Q37067814-0635F433-2CE9-4F3C-8C24-7FE41FE293F4

P356

Q37067814-039F4613-9D65-4A3E-9966-7FC9F0665DD8

P433

Q37067814-2F34BCC5-9137-4F7C-9F04-E373DD11C1C3

P478

Q37067814-CE2BAB78-E3D5-4543-9375-446C94CB8FA1

P50

Q37067814-16C10A13-5F86-4580-9BD6-F14BA3E9C2CD

Q37067814-610BF931-DB0D-42D5-AA30-291737735139

Q37067814-C7000739-6DE9-4756-9AC9-8E85D6E3E7AC

P577

Q37067814-A1501321-ACA5-4DB2-B204-79AFA623EDB6

P5875

Q37067814-09E55EB5-4F58-49F1-8645-16EAF396D387

P698

Q37067814-2F7C85EB-D878-408C-9849-4C4C79F8E153

P921

Q37067814-5AEE5D05-5C61-4381-B4ED-24A0D14DB685

P932

Q37067814-F7610C33-7EB4-496F-9FA9-AAB5DE92DEBD

P356

ARCHNEUR.65.9.1202

P1433

P1476

Measuring cerebral atrophy and ...... e decline in Alzheimer disease

@en

P2093

Adam M Brickman

http://www.w3.org/2001/XMLSchema#string

Lawrence S Honig

http://www.w3.org/2001/XMLSchema#string

Linda Sanders

http://www.w3.org/2001/XMLSchema#string

Marilyn S Albert

http://www.w3.org/2001/XMLSchema#string

Nikolaos Scarmeas

http://www.w3.org/2001/XMLSchema#string

Oksana Tatarina

http://www.w3.org/2001/XMLSchema#string

P2860

“Mini-mental state”

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

The cognitive correlates of white matter abnormalities in normal aging: a quantitative review.

Shifting paradigms in dementia: toward stratification of diagnosis and treatment using MRI.

Ventricular volume and dementia progression in the Cardiovascular Health Study.

Motor signs during the course of Alzheimer disease.

Motor signs predict poor outcomes in Alzheimer disease.

White matter hyperintensities are significantly associated with cortical atrophy in Alzheimer's disease

Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study.

Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease

P304

1202-1208

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/ARCHNEUR.65.9.1202

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

65

http://www.w3.org/2001/XMLSchema#string

P50

Deborah Blacker

P577

2008-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23245198

http://www.w3.org/2001/XMLSchema#string

P698

18779424

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

2629007

http://www.w3.org/2001/XMLSchema#string